Decheng Capital LLC
Q4 2024 13F Holdings
- Locationmenlo park, CA
- Num holdings
28
- Value ($000)
$466,229
- Date Filed02/14/2025
- Form type13F-HR
- CIK0002010850
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2024 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
CGON CG ONCOLOGY INC | COM | 156944100 | $182.74M | 39 % | 6,371,669 | ||
NUVB Nuvation Bio Inc. | COM | 67080N101 | $69.04M | 15 % | 25,954,439 | ||
Upstream Bio Inc. | COM | 91678A107 | $54.01M | 12 % | 3,285,293 | ||
NEWAMSTERDAM PHARMA CO NV | COM | N62509109 | $19.79M | 4 % | 770,000 | ||
ILMN Illumnia, Inc. | COM | 452327109 | $12.66M | 3 % | 94,767 | ||
RCUS Arcus Biosciences, Inc | COM | 03969F109 | $12.04M | 3 % | 808,789 | ||
KRYS KRYSTAL BIOTECH INC | COM | 501147102 | $12.03M | 3 % | 76,772 | ||
RVMD REVOLUTION MEDICINES INC(NSM) | COM | 76155X100 | $9.89M | 2 % | 226,000 | ||
MOONLAKE IMMUNOTHERAPEUTICS | COM | G4444C102 | $9.29M | 2 % | 171,600 | ||
CRNX CRINETICS PHARMACEUTICALS IN | COM | 22663K107 | $8.59M | 2 % | 167,958 |
Rows Per Page
1 - 10 of 2810
- 10
- 50
- 100